{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T06:44:38Z","timestamp":1791960278261,"version":"4.3.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1016\/j.arcmed.2005.03.019","type":"journal-article","created":{"date-parts":[[2005,6,10]],"date-time":"2005-06-10T11:47:16Z","timestamp":1118404036000},"page":"387-392","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Lipid Profile and Anticardiolipin Antibodies in Behcet's Disease"],"prefix":"10.1016","volume":"36","author":[{"given":"Ugur","family":"Musabak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orhan","family":"Baylan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Turker","family":"Cetin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeki","family":"Yesilova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Sengul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenan","family":"Saglam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Inal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail H.","family":"Kocar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2005.03.019_bib1","first-page":"1152","article-title":"Uber rezidivierende apthose, durch ein virus verursachte geschwure am mund, am auge und an den genitalien","volume":"105","author":"Beh\u00e7et","year":"1937","journal-title":"Dermatol Wochenschr"},{"key":"10.1016\/j.arcmed.2005.03.019_bib2","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S1078-5884(96)80178-X","article-title":"Venous lesions in Behcet's disease","volume":"11","author":"Sagdic","year":"1996","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.arcmed.2005.03.019_bib3","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1136\/ard.43.5.746","article-title":"Anticardiolipin antibodies: occurrence in Behcet's syndrome","volume":"43","author":"Hull","year":"1984","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.arcmed.2005.03.019_bib4","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/BF02030089","article-title":"Anticardiolipin antibodies in Behcet's syndrome: a predictor of a more severe disease","volume":"8","author":"Pereira","year":"1989","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.arcmed.2005.03.019_bib5","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/096120339400300503","article-title":"Antiphospholipid antibodies, thrombosis and atherosclerosis in systemic lupus erythematosus: a unifying `membrane stress syndrome' hypothesis","volume":"3","author":"Ames","year":"1994","journal-title":"Lupus"},{"key":"10.1016\/j.arcmed.2005.03.019_bib6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0021-9150(77)90197-6","article-title":"Dyslipoprotaeinemia in patients with active, chronic polyarthritis. A study on serum lipoproteins and triglyceride clearance (intravenous fat tolerance test)","volume":"28","author":"Rossner","year":"1977","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.arcmed.2005.03.019_bib7","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1002\/art.1780361111","article-title":"Low levels of total cholesterol, high-density lipoprotein, and apolipoprotein A1 in association with anticardiolipin antibodies in patients with systemic lupus erythematosus","volume":"36","author":"Lahita","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.arcmed.2005.03.019_bib8","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/0009-9120(93)80016-N","article-title":"Influence of serum amyloid A protein on high-density lipoprotein in chronic inflammatory disease","volume":"26","author":"Kumon","year":"1993","journal-title":"Clin Biochem"},{"key":"10.1016\/j.arcmed.2005.03.019_bib9","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0009-8981(88)90103-9","article-title":"Lipoprotein cholesterol concentrations in patients with Behcet's disease","volume":"175","author":"Mitamura","year":"1988","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.arcmed.2005.03.019_bib10","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1136\/heart.84.2.208","article-title":"Increased plasma lipoprotein (a) concentrations in Behcet's disease and its relation to vascular events","volume":"84","author":"Erem","year":"2000","journal-title":"Heart"},{"key":"10.1016\/j.arcmed.2005.03.019_bib11","first-page":"249","article-title":"Lipoprotein(a): structure, biology and clinical relevance","volume":"36","author":"Scanu","year":"1991","journal-title":"Adv Intern Med"},{"key":"10.1016\/j.arcmed.2005.03.019_bib12","first-page":"1078","article-title":"Criteria for diagnosis of Behcet's disease","volume":"335","author":"International Study Group for Behcet's Disease","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.arcmed.2005.03.019_bib13","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/0002-9343(85)90224-4","article-title":"Erythrocyte sedimentation rate. From folklore to facts","volume":"76","author":"Bedell","year":"1985","journal-title":"Am J Med"},{"key":"10.1016\/j.arcmed.2005.03.019_bib14","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/clinchem\/25.4.596","article-title":"Comparison of current methods for high-density lipoprotein cholesterol quantitation","volume":"25","author":"Warnick","year":"1979","journal-title":"Clin Chem"},{"key":"10.1016\/j.arcmed.2005.03.019_bib15","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"10.1016\/j.arcmed.2005.03.019_bib16","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1468-3083.2004.00907.x","article-title":"Serum interleukin-6, procalcitonin and C-reactive protein levels in subject with active Behcet's disease","volume":"18","author":"Adam","year":"2004","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.arcmed.2005.03.019_bib17","series-title":"Behcet's Syndrome: Clinical and Immunological Features","first-page":"267","article-title":"Corticosteroid and azathioprine; their use in Behcet's syndrome","author":"Lessof","year":"1979"},{"key":"10.1016\/j.arcmed.2005.03.019_bib18","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1001\/archinte.1987.00370110040005","article-title":"Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. I. Relativity to inflammatory activity","volume":"147","author":"Svenson","year":"1987","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.arcmed.2005.03.019_bib19","first-page":"473","article-title":"Plasma lipoprotein (a) and its relationship with disease activity in patients with Behcet's disease","volume":"33","author":"Orem","year":"1995","journal-title":"J Clin Chem Clin Biochem"},{"key":"10.1016\/j.arcmed.2005.03.019_bib20","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1136\/ard.54.9.726","article-title":"Lp(a) lipoprotein levels as a predictor of risk for thrombogenic events in patients with Behcet's disease","volume":"54","author":"Orem","year":"1995","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.arcmed.2005.03.019_bib21","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1346-8138.1990.tb01619.x","article-title":"Anticardiolipin antibodies in Behcet's disease","volume":"17","author":"Bergman","year":"1990","journal-title":"J Dermatol"},{"key":"10.1016\/j.arcmed.2005.03.019_bib22","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/BF02231554","article-title":"Association of anti-cardiolipin antibodies with vascular thrombosis and neurological manifestation of Behcet's disease","volume":"12","author":"al-Dalaan","year":"1993","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.arcmed.2005.03.019_bib23","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2133.1993.tb00172.x","article-title":"Anticardiolipin antibodies in Adamantiades-Behcet's disease","volume":"128","author":"Zouboulis","year":"1993","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.arcmed.2005.03.019_bib24","first-page":"411","article-title":"Markers of vascular injury in Behcet's disease associated with retinal vasculitis","volume":"24","author":"Pivetti-Pezzi","year":"1992","journal-title":"Ann Ophthalmol"},{"key":"10.1016\/j.arcmed.2005.03.019_bib25","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/rheumatology\/40.2.192","article-title":"Anticardiolipin antibodies in Behcet's Disease: a reassessment","volume":"40","author":"Tokay","year":"2001","journal-title":"Rheumatology"},{"key":"10.1016\/j.arcmed.2005.03.019_bib26","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3346\/jkms.1998.13.4.400","article-title":"Anticardiolipin and anti-beta2-glycoprotein I antibodies in Behcet's Disease","volume":"13","author":"Kang","year":"1998","journal-title":"J Korean Med Sci"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440905000925?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440905000925?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:29:44Z","timestamp":1759260584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440905000925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S0188440905000925"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2005.03.019","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipid Profile and Anticardiolipin Antibodies in Behcet's Disease","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2005.03.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 IMSS. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}